Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 8, 2005, Pages 552-558

  Pietschmann, Andrea ^a,c   Mehdipour, Parvin ^a,b,c   Atri, Morteza ^b   Hofmann, Wera ^c   Hosseini Asl, S Said ^b   Scherneck, Siegfried ^c   Mundlos, Stefan ^a   Peters, Hartmut ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

BRCA1; BRCA2; Breast cancer; Iran; Mutation; Ovarian cancer; Unclassified variants

Indexed keywords

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FAMILY; FEMALE; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; GENE SEQUENCE; GERM LINE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INHERITANCE; INTRON; IRAN; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; IRAN; MIDDLE AGED; PEDIGREE; PENETRANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 24044446170     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0678-8     Document Type: Article

References (21)

1. den Dunnen JT, Antonarakis E (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
2. Diez O, Osorio A, Duran M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodriguez-Lopez R, Velasco E, Chaves J, Diaz-Rubio E, Jesus Cruz J, Torres M, Esteban E, Cervantes A, Alonso C, San Roman JM, Gonzalez-Sarmiento R, Miner C, Carracedo A, Eugenia Armengod M, Caldes T, Benitez J, Baiget M (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22(4):301-312
3. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frenay M, Gilbert B, Maugard C, Bignon YJ, Chevrier A, Rossi A, Fricker JP, Nguyen TD, Demange L, Aurias A, Bensimon A und Stoppa-Lyonnet D (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21(44):6841-6847
4. Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H (2001) Germline BRCA1 mutations in Iranian women with breast cancer. Cancer Lett 165:87-94
5. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risks. Cancer Epidemiol Biomarkers Prev 11:1513-1530
6. Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26:362-364
7. Hofmann W, Wappenschmidt B, Berhane S, Schmutzler R, Scherneck S (2002) Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. J Med Genet 39:E36
8. King MC, Marks JH, Mandell JB (2003) Breast and ovarien cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646
9. Liede A, Narod S (2002) Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424
10. Liu X, Barker DF (1999) Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. Am J Hum Genet 64:1427-1439
11. Mehdipour P, Atri M, Jafarimojarrad E, Hosseini-Asl SS, Javidroozi M (2003) Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pacific J Cancer Prev 4:185-192
12. Mosavi-Jarrahi A, Mohagheghi MA, Zeraatti H, Mortazavi H (2001) Cancer registration in Iran. Asian Pacific J Cancer Prev (IACR) 2:25-29
13. Moslehi R, Kariminejad M, Ghaffari V, Narod S (2003) Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome. Am J Med Genet 117A:304-305
14. Najmabadi H, Neishabury M, Sahebjam F, Kahrizi K, Shafaghati Y, Nikzat N, Jalalvand M, Aminy F, Hashemi S, Moghimi B, Noorian A, Jannati A, Mohammadi M, Javan K (2003) The Iranian Human Mutation Gene Bank: a data and sample resource for worldwide collaborative genetics research. Hum Mutat 21:146-150
15. Neuhausen S (2000) Founder populations and their uses for breast cancer genetics. Breast Cancer Res 2:77-81
16. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278(15):1242-1250
17. The BRCA1 Exon 13 Duplication Screening Group 2000 (2000) The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 67:207-212
18. The Breast Cancer Information Core - database. (http://www.nchgr.nih.gov/ Intramural_research/Lab_transfer/Bic)
19. Thompson D, Easton D; Breast Cancer Linkage Consortium (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68(2):410-419
20. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841-850
21. Yassaee V, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi M, Hornby D, Dalton A (2002) Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res 4:R6